Related Experiment Video
Updated: May 13, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Treatment of hypertension as a risk factor in a prospective study
H L Thürmer1, P G Lund-Larsen, A Tverdal
1National Health Screening Service, Oslo, Norway.
Insights
Blood pressure treatment in a real-world setting was linked to higher mortality rates. This study suggests treatment outcomes may be worse than in clinical trials, especially for those on medication.
Area of Science:
- Cardiovascular epidemiology
- Public health research
- Clinical outcomes analysis
Background:
- Blood pressure management is crucial for cardiovascular health.
- Real-world effectiveness of hypertension treatment requires ongoing investigation.
- Previous studies often focus on controlled clinical trial data.
Purpose of the Study:
- To examine the association between blood pressure treatment, blood pressure levels, and mortality.
- To compare mortality risks in individuals receiving blood pressure medication versus those not treated.
- To investigate the relationship between blood pressure and mortality, considering cardiovascular risk factors.
Main Methods:
- A 12-year follow-up study of a cardiovascular risk factor screening.
- Inclusion of 33,154 men and 16,407 women aged 40-49 with complete blood pressure and treatment data.
- Analysis of mortality from coronary heart disease, stroke, and all causes, stratified by treatment status and blood pressure levels.
Main Results:
- Individuals on blood pressure medication showed significantly higher mortality from cardiovascular disease and all causes.
- A J-shaped association between blood pressure and mortality was observed in the treated group.
- Excess mortality was noted even after accounting for previous myocardial infarction or stroke.
Conclusions:
- Blood pressure treatment in this population was associated with increased all-cause mortality.
- Real-world treatment outcomes may be inferior to those reported in controlled clinical trials.
- A J-shaped relationship between blood pressure and mortality exists for men on treatment.
Abstract:
The association between blood pressure treatment, blood pressure level and mortality, taking other cardiovascular risk factors into account was studied. A 12-year follow-up of a cardiovascular risk factor screening performed by the Oslo study group in Oslo and by ambulatory teams from the National Health Screening Survey in three counties in Norway was done. All men in Oslo and all men and women in the three counties, (age 40-49) participated, of these 33154 men and 16407 women have complete data on blood pressure and treatment, including subjects reporting previous myocardial infarction or stroke. Mortality from coronary heart disease, stroke and all causes by blood pressure treatment and blood pressure level were studied. At the initial screening 1058 men and 817 women reported taking blood pressure medication, of which 201 and 41 died during follow-up. Total number of deaths were 2341 in men and 421 in women, of these 131 deaths in men and 47 in women reporting previous infarction or stroke. Those reporting blood pressure treatment had a marked excess mortality from cardiovascular disease and all causes of death. A J-shaped association between blood pressure and mortality was marked in the treated group, but weak in those not on treatment. It is concluded that blood pressure treatment is associated with excess mortality from all causes. This may indicate that "real life" treatment outcomes are inferior to those reported from controlled clinical trials. There is a J-shaped association between all cause mortality and blood pressure in men on treatment.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology